Blood-brain barrier monoamine metabolism regulation of social behavior

摘要 血脑屏障是一个用来描述血管形成的独特性质的术语。 中枢神经系统。这些血管严格控制离子、分子和细胞的运动。 在血液和大脑之间，从而控制神经组织的细胞外环境。尽管 血脑屏障的重要性，我们对血脑屏障如何调节神经知之甚少。 环境来调节复杂的行为。我们已经确定了产生的代谢酶 单胺类神经递质多巴胺和5-羟色胺在血管内皮细胞中富含 提示血脑屏障代谢可能调节中枢神经系统血管 这些单胺类神经递质的水平对许多复杂行为至关重要。在预赛中 我们的研究发现，内皮细胞中这些酶的缺失会导致社会功能缺陷 相互作用，并进一步发现证据表明，这些血管酶起到代谢缓冲的作用 单胺前体的运输。有趣的是，编码这些基因的基因的多态 酶已经与自闭症的风险和/或严重性联系在一起，然而作用部位和机制通过 他们对自闭症相关行为的调节尚不清楚。在这里，我们将检验一种假设，即血脑 屏障代谢调节自闭症相关行为，包括社会互动。我们会进一步研究 血脑屏障代谢调节单胺类神经递质水平的机制 在中枢神经系统内，以及这如何影响行为。我们的最终目标是确定 血脑屏障是调节行为的治疗靶点。

Abstract The blood-brain barrier is a term used to describe the unique properties of the blood vessels that vascularize the central nervous system. These blood vessels tightly regulate the movement of ions, molecules and cells between the blood and the brain, thus controlling the extracellular environment of the neural tissue. Despite the importance of the blood-brain barrier, very little is known about how this barrier regulates the neural environment to modulate complex behaviors. We have identified that the metabolic enzymes that generate and breakdown the monoamine neurotransmitters dopamine and serotonin are enriched in the endothelial cells of central nervous system blood vessels, suggesting that blood-brain barrier metabolism may regulate the levels of these monoamine neurotransmitters which are critical for many complex behaviors. In preliminary studies we have identified that deletion of these enzymes in endothelial cells leads to deficits in social interaction, and have further found evidence that these vascular enzymes act as a metabolic buffer to the transport of monoamine precursors. Interestingly, polymorphisms in the genes encoding each of these enzymes have been linked with autism risk and/or severity, however the site of action and mechanism by which they regulate autism-related behaviors is not known. Here we will test the hypothesis that blood-brain barrier metabolism regulates autism-related behaviors including social interaction. We will further examine the mechanism by which blood-brain barrier metabolism may regulate the levels of monoamine neurotransmitters within the central nervous system, and how this affects behavior. Our ultimate goal is to determine whether the blood-brain barrier is a therapeutic target to modulate behavior.